Efficacy and Safety of Percutaneous Transhepatic Portal Embolization before Right Liver Resection Using an Ethibloc/Lipiodol Mixture: A Single-Center Experience
Authors:
- B. RadeleffBRB. Radeleff
- S. SchawoSSS. Schawo
- K. HoffmannKHK. Hoffmann
- P. SchemmerPSP. Schemmer
- G. NoeldgeGNG. Noeldge
- G.W. KauffmannGKG.W. Kauffmann
- B. FroehlichBFB. Froehlich
- G.M. RichterGRG.M. Richter
- 25 February 2008
- journal article
- Published by S. Karger AG in Digestive Surgery
- Vol. 25 (1) , 52-59
Abstract
Aim: The purpose of this study was to evaluate the safety and efficacy of percutaneous transhepatic portal vein embolization of the right portal vein with an Ethibloc/Lipiodol mixture to induce hypertrophy of the left liver lobe in patients with primarily unresectable liver tumor. Methods: 15 patients (8 primary liver tumors, 7 liver metastases) underwent portal vein embolization. Liver volumetry, duration of hospitalization, complication rates, relevant laboratory values were documented. Results: In 13/15 patients (84.6%) embolization could be performed with a median of 8.8 ml (range 1.5–28 ml) Ethibloc/Lipiodol. One minor procedure-related complication (subcapsular hematoma) occurred, which did not affect the two-step liver resection. No patient developed acute liver failure after embolization or liver resection. The volume of the left liver lobe increased significantly (p = 0.0015) by 25% from a median of 750 ml (587–1,114 ml) to 967 ml (597–1,249 ml). 11/13 (81.8%) of the embolized patients underwent liver resection at a median of 49 days after embolization. Median hospitalization time was 4 days after embolization and 7 days after liver resection. Median overall survival of the 11 operated patients was 376 days. Conclusion: Percutaneous transhepatic portal vein embolization using an Ethibloc/Lipiodol mixture is a safe, feasible, and efficient interventional procedure.Keywords
This publication has 26 references indexed in Scilit:
- Partielle Pfortaderembolisation als Vorbereitung zur ausgedehnten Leberteilresektion: eine interdisziplinäre HerausforderungRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2007
- Lebermetastasen kolorektaler Karzinome - Neoadjuvante Konzepte zum präoperativen DownstagingZentralblatt fur Chirurgie, 2006
- Safety and Efficacy of Preoperative Portal Vein Embolization with Polyvinyl Alcohol in 58 Patients with Liver MetastasesAmerican Journal of Roentgenology, 2005
- Transhepatic Ipsilateral Right Portal Vein Embolization Extended to Segment IV: Improving Hypertrophy and Resection Outcomes with Spherical Particles and CoilsJournal of Vascular and Interventional Radiology, 2005
- Volumetric Analysis Predicts Hepatic Dysfunction in Patients Undergoing Major Liver ResectionJournal of Gastrointestinal Surgery, 2003
- Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system11No competing interests declared.Journal of the American College of Surgeons, 1999
- Preoperative Portal Vein Embolization for Extension of Hepatectomy IndicationsHepatology, 1996
- Selective portal vein embolization with absolute ethanol induces hepatic hypertrophy and makes more extensive hepatectomy possibleHepatology, 1996
- Experimental Study of the Effectiveness of Capillary Embolization Using Contrast-Enhanced Ethibloc®Investigative Radiology, 1984
- Kapillare EmbolisationRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1980